| AIORX | OSMNX | AIORX / OSMNX | |
| Total Expense Ratio | 1.96 | 1.63 | 120% |
| Annual Report Gross Expense Ratio | 2.01 | 1.63 | 123% |
| Fund Existence | 16 years | 25 years | - |
| Gain YTD | 9.833 | 2.780 | 354% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 547M | 2.56B | 21% |
| Annual Yield % from dividends | 0.00 | 1.26 | - |
| Returns for 1 year | 40.88 | -4.35 | -939% |
| Returns for 3 years | 42.81 | -15.32 | -279% |
| Returns for 5 years | -8.28 | -34.89 | 24% |
| Returns for 10 years | 56.66 | 4.80 | 1,180% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIOCX | 11.64 | 0.16 | +1.39% |
| American Century International Opps C | |||
| FVILX | 6.30 | 0.07 | +1.12% |
| Forester Value I | |||
| GIRVX | 8.98 | 0.01 | +0.11% |
| Goldman Sachs Intl Eq Div & Prem Inv | |||
| GIEYX | 16.54 | N/A | N/A |
| GuideStone Funds International Eq Instl | |||
| JFNSX | 77.29 | -0.49 | -0.63% |
| Janus Henderson Global Life Sciences S | |||